We found that a tumor mutation (F87L) in DAXX reduces the binding affinity with the ATRX DBM to 33.8 μM (about 38-fold reduction) (Fig. 1g; Supplementary Fig. 6a). This evidence concerns the gene ATRX and neoplasm.